The International Thermonuclear Experimental Reactor (ITER) will be relying on tungsten as its plasma-facing material, but a ...

Plus Therapeutics (PSTV) and SpectronRx announced the signing of a Manufacturing Services Agreement, MSA, for the production of Rhenium ...

Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda ...

德克萨斯州奥斯汀 - 临床阶段制药公司Plus Therapeutics, Inc. (NASDAQ:PSTV)与放射性药物合同开发和制造商SpectronRx合作,生产用于中枢神经系统 (CNS)癌症的先进放射疗法。今天宣布的制造服务协议 (MSA)聚焦于Rhenium (186Re) Obisbemeda,该疗法旨在治疗CNS癌症,包括脑膜转移和复发性胶质母细胞瘤。

Plus Therapeutics has partnered with SpectronRx for the production of Rhenium (186Re) obisbemeda, a targeted radiotherapy for ...

India and Kazakhstan have partnered to establish IREUK Titanium Limited. The joint venture will produce Titanium Slag in ...

Highlights: NW24-27 included a 120m interval grading 0.57g/t Au Eq. and an additional 48m grading 0.35g/t Au Eq., and was successful in testing ...

BWX Technologies, Inc. (NYSE: BWXT) and L3Harris Technologies, Inc. (NYSE: LHX) today announced the signing of a purchase agreement for BWXT to acquire L3Harris' Aerojet Ordnance Tennessee, Inc.

Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal metastases (LM) and discuss its plan for continued clinical development ...

Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186 Re) Obisbemeda for leptomeningeal metastases (LM) and discuss its plan for continued clinical development ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...